Brucellosis. Brucellosis, unspecified
Conditions
Interventions
Intervention 1: Control group: Doxycycline capsule, 100 mg BD for 2 months + Rifampin capsule 300 mg daily for 2 months. Intervention 2: Intervention group: Doxycycline 100 mg BD for 2 months + Rifamp
Treatment - Drugs
Control group: Doxycycline capsule, 100 mg BD for 2 months + Rifampin capsule 300 mg daily for 2 months
Intervention group: Doxycycline 100 mg BD for 2 months + Rifampin 600 mg for 2 months as well as Dexamethasone 4 mg, IV, TDS for 5 days
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to 83 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Documented brucellosis patients with the age 12 years and more Exclusion criteria: history of addiction, corticosteroid use, Immunodeficiency
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of admission. Timepoint: total days of admission. every day. Method of measurement: Hospital patienst records.;Pain. Timepoint: daily. Method of measurement: patient's complaint and physical examinations.;Clinical status. Timepoint: daily. Method of measurement: physical examination.;Analgesic usage. Timepoint: daily. Method of measurement: Based on the medical orders and nursing records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's stability. Timepoint: daily. Method of measurement: physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsaneh Karami
Zanjan University of Medical Sciences
Outcome results
None listed